CClinicalTrials.gg
SuspendedNCT03907449Updated Jul 9, 2019

Preview Rapid Strep A Test Method Comparison Study

An observational study in Strep Throat, sponsored by Guangzhou Wondfo Biotech Co., Ltd. Suspended at 2 sites in United States. Open to participants aged 3 Years and older. Per ClinicalTrials.gov, last updated 2019-07-09.

Sponsored by Guangzhou Wondfo Biotech Co., Ltd · Observational

Why this study was suspended
Recruitment rates reduced during non-Strep season
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
320
Ages
3 Years and older
Sex
All
01

Study summary

This study is designed to determine the accuracy of the Preview Rapid Strep A Test compared to a laboratory reference method for Group A Streptococcal infection and to determine the precision of the Preview Rapid Strep A test.

02

Conditions studied

  • Strep Throat
03

In context

Streptococcal Infections

155 studies on the registry are indexed under Streptococcal Infections; 15 are open to participants now.

This study's planned enrollment of 320 is close to the median of 339 across 42 observational studies indexed under Streptococcal Infections.

Browse Streptococcal Infections studies →

Lead sponsor

Guangzhou Wondfo Biotech Co., Ltd is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Approximately 320 patients to be tested, expecting 50-100 positive for Strep A collected from patients of any age and gender from two CLIA waived or waivable sites. Children will be enrolled in this study due to the high prevalence of Strep A infections in minors and the intention to market this investigational device for use for all ages following FDA clearance.

Inclusion criteria

  • Any patient presenting with symptoms of pharyngitis

    • Fever
    • Sore throat
    • Swollen lymph nodes in neck
    • Redness of throat/tonsils
    • White/yellow patches on tonsils
    • Not currently on antibiotics
  • ≥3 years or older
  • Ability to read, understand and sign a consent form, in English, or for parent(s) to sign an assent form providing permission to include children under the age of 18.

Exclusion criteria

Exclusion Criteria:

  • Currently taking antibiotics
  • Previously enrolled in this study
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
320 participants (estimated)
Patient registry
No

Groups and cohorts

  • Symptoms of Strep Throat

    Any patient presenting with symptoms of pharyngitis * Fever * Sore throat * Swollen lymph nodes in neck * Redness of throat/tonsils * White/yellow patches on tonsils * Not currently on antibiotics

    Diagnostic Test: Preview Rapid Strep A test

Interventions

  • Diagnostic testPreview Rapid Strep A test

    Rapid assay for the detection of type A streptococcal infection of the throat.

06

What researchers measure

Primary outcomes

  1. Accuracy of Preview Strep A Rapid Test

    Determination of Positive Predictive Value and Negative Predictive Value for Preview Strep A

    Time frame: 3 months

07

Study locations

2 sites
  • UHSH Microbiology
    Johnson City, New York 13790, United States
  • Summerwood Pediatrics
    Liverpool, New York 13088, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 9, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03907449
Lead sponsor
Guangzhou Wondfo Biotech Co., Ltd
Responsible party
Sponsor
First posted
Apr 9, 2019
Start date
Mar 19, 2019
Primary completion
May 2020 (estimated)
Completion
May 2020 (estimated)
Last update
Jul 9, 2019

Study contacts

Paul Granato, PhD
principal investigator · UHSH Microbiology
Jagmohan Sidhu, MD
principal investigator · UHSH Microbiology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is suspended, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion